期刊
FRONTIERS IN CELLULAR NEUROSCIENCE
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fncel.2015.00297
关键词
Alzheimer'sdisease; beta-amyloid; glucose; IGF-IR; Glut3
资金
- Italian Ministry of University and Research [FIRBMERITRBNE08HWLZ]
- Italian Ministry of Health [RF-2010-2314258]
beta-amyloid (A beta(1-42)) is produced by proteolytic cleavage of the transmembrane type-1 protein, amyloid precursor protein. Under pathological conditions, A beta(1-42)self-aggregates into oligomers, which cause synaptic dysfunction and neuronal loss, and are considered the culprit of Alzheimer's disease (AD). However, A beta(1-42) is mainly monomeric at physiological concentrations, and the precise role of monomeric A beta(1-42) in neuronal function is largely unknown. We report that the monomer of A beta(1-42) activates type-1 insulin-like growth factor receptors and enhances glucose uptake in neurons and peripheral cells by promoting the translocation of the Glut3 glucose transporter from the cytosol to the plasma membrane. In neurons, activity-dependent glucose uptake was blunted after blocking endogenous A beta production, and re-established in the presence of cerebrospinal fluid A beta. APP-null neurons failed to enhance depolarization-stimulated glucose uptake unless exogenous monomeric A beta(1-42) was added. These data suggest that A beta(1-42) monomers were critical for maintaining neuronal glucose homeostasis. Accordingly, exogenous A beta(1-42) monomers were able to rescue the low levels of glucose consumption observed in brain slices from AD mutant mice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据